CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 499 enrolled
Drug / intervention
Quartet 1457Q LV Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02548455
NCT02548455N/ACompleted
CompareCT.gov

A Clinical Evaluation of the Safety of the St. Jude Medical Quartet 1457Q Left Ventricular Lead, an IDE Study

Abbott Medical Devices·interventional·Posted Sep 14, 2015·Updated Feb 4, 2019

In Brief

A clinical study evaluating Quartet 1457Q LV Lead for Heart Failure. Completed, enrolled 499 participants across 30 sites.

Detailed Summary

The primary intent of this study is to assess the safety of the model 1457Q Quartet LV lead at 3 months in a patient population indicated for cardiac resynchronization therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 14, 2015
Enrollment StartOct 27, 2015
Primary CompletionAug 19, 2016
Study CompletionMar 21, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.8 years ago

Interventions

Quartet 1457Q LV Leaddevice